3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Urinary Bladder Neoplasms
17
Colorectal Neoplasms
17
Non-Muscle Invasive Bladder Neoplasms
10
Neoplasm Metastasis
10
Stomach Neoplasms
9
Appendiceal Neoplasms
9
Anus Neoplasms
9
Peritoneal Neoplasms
8
Carcinoma, Hepatocellular
8
Pancreatic Neoplasms
5
Liver Neoplasms
4
Colonic Neoplasms
4
Pseudomyxoma Peritonei
3
Carcinoma, Transitional Cell
3
Carcinoma, Non-Small-Cell Lung
3
Uterine Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Rectal Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Head and Neck Neoplasms
2
Gastrointestinal Neoplasms
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Urothelial Carcinoma of the Bladder
1
Urothelial Carcinoma Ureter
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Interventions
Pemetrexed
22
Cisplatin
20
Nivolumab
8
Gemcitabine
7
Carboplatin
7
durvalumab
5
Ipilimumab
5
Bevacizumab
5
pembrolizumab
4
Radiotherapy, Intensity-Modulated
4
tremelimumab
3
niraparib
3
Oxaliplatin
3
Drug Therapy
3
Cyclophosphamide
3
Cerebral Decortication
3
Blood Specimen Collection
3
sargramostim
2
Thoracoscopy
2
Surveys and Questionnaires
2
Sorafenib
2
Radiosurgery
2
Magnesium Sulfate
2
Leucovorin
2
Imatinib Mesylate
2
Hyperthermic Intraperitoneal Chemotherapy
2
Doxorubicin
2
Dexamethasone
2
tislelizumab
1
spartalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Mesothelioma
×
Mitomycin
×
Clear all
NCT00454519
2009-02-13
IPHC
Wuhan University
Phase 2
Unknown
60 enrolled